Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model

Patients with stable coronary artery disease (CAD) are at an increased risk of acute myocardial infarction (AMI), particularly among older individuals. Developing a reliable model to predict AMI occurrence in these patients holds the potential to expedite early diagnosis and intervention. This study...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Jing Zhao, Yong Li, Feng-Xiang Wang, Hao Lv, Yaoyao Qu, Lian-Wen Qi, Pingxi Xiao
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2024/9935805
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832543606008709120
author Yi-Jing Zhao
Yong Li
Feng-Xiang Wang
Hao Lv
Yaoyao Qu
Lian-Wen Qi
Pingxi Xiao
author_facet Yi-Jing Zhao
Yong Li
Feng-Xiang Wang
Hao Lv
Yaoyao Qu
Lian-Wen Qi
Pingxi Xiao
author_sort Yi-Jing Zhao
collection DOAJ
description Patients with stable coronary artery disease (CAD) are at an increased risk of acute myocardial infarction (AMI), particularly among older individuals. Developing a reliable model to predict AMI occurrence in these patients holds the potential to expedite early diagnosis and intervention. This study is aimed at establishing a circulating amino acid-assisted model, incorporating amino acid profiles alongside clinical variables, to predict AMI risk. A cohort of 874 CAD patients from two independent centers was analyzed. Plasma amino acid levels were quantified using liquid chromatography tandem mass spectrometry (LC-MS/MS) employing a targeted metabolomics approach. This methodology incorporated 13C isotope-labeled internal standards for precise quantification of 27 amino acids. Univariate logistic regression was applied to identify differentially expressed amino acids that distinguished between stable CAD and AMI patients. To assess prediction performance, receiver operating characteristic (ROC) curve and nomogram analyses were utilized. Five amino acids—lysine, methionine, tryptophan, tyrosine, and N6-trimethyllysine—emerged as potential biomarkers (p<0.05), exhibiting significant differences in their expression levels across the two centers when comparing stable CAD with AMI patients. For AMI risk prediction, the base model, utilizing 12 clinical variables, achieved areas under the curve (AUC) of 0.7387 in the discovery phase (n=623) and 0.8205 in the external validation set (n=251). Notably, the integration of these five amino acids into the prediction model significantly enhanced its performance, increasing the AUC to 0.7651 in the discovery phase (Delong’s test, p=1.43e‐02) and to 0.8958 in the validation set (Delong’s test, p=8.91e‐03). In conclusion, the circulating amino acid-assisted model effectively enhances the prediction of AMI risk among CAD patients, indicating its potential clinical utility in facilitating early detection and intervention.
format Article
id doaj-art-e7fc5ecfad0644c5b9ac790d21e2adcb
institution Kabale University
issn 1755-5922
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Cardiovascular Therapeutics
spelling doaj-art-e7fc5ecfad0644c5b9ac790d21e2adcb2025-02-03T11:37:51ZengWileyCardiovascular Therapeutics1755-59222024-01-01202410.1155/2024/9935805Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted ModelYi-Jing Zhao0Yong Li1Feng-Xiang Wang2Hao Lv3Yaoyao Qu4Lian-Wen Qi5Pingxi Xiao6State Key Laboratory of Natural MedicinesDepartment of CardiologyThe Clinical Metabolomics CenterState Key Laboratory of Natural MedicinesState Key Laboratory of Natural MedicinesState Key Laboratory of Natural MedicinesDepartment of CardiologyPatients with stable coronary artery disease (CAD) are at an increased risk of acute myocardial infarction (AMI), particularly among older individuals. Developing a reliable model to predict AMI occurrence in these patients holds the potential to expedite early diagnosis and intervention. This study is aimed at establishing a circulating amino acid-assisted model, incorporating amino acid profiles alongside clinical variables, to predict AMI risk. A cohort of 874 CAD patients from two independent centers was analyzed. Plasma amino acid levels were quantified using liquid chromatography tandem mass spectrometry (LC-MS/MS) employing a targeted metabolomics approach. This methodology incorporated 13C isotope-labeled internal standards for precise quantification of 27 amino acids. Univariate logistic regression was applied to identify differentially expressed amino acids that distinguished between stable CAD and AMI patients. To assess prediction performance, receiver operating characteristic (ROC) curve and nomogram analyses were utilized. Five amino acids—lysine, methionine, tryptophan, tyrosine, and N6-trimethyllysine—emerged as potential biomarkers (p<0.05), exhibiting significant differences in their expression levels across the two centers when comparing stable CAD with AMI patients. For AMI risk prediction, the base model, utilizing 12 clinical variables, achieved areas under the curve (AUC) of 0.7387 in the discovery phase (n=623) and 0.8205 in the external validation set (n=251). Notably, the integration of these five amino acids into the prediction model significantly enhanced its performance, increasing the AUC to 0.7651 in the discovery phase (Delong’s test, p=1.43e‐02) and to 0.8958 in the validation set (Delong’s test, p=8.91e‐03). In conclusion, the circulating amino acid-assisted model effectively enhances the prediction of AMI risk among CAD patients, indicating its potential clinical utility in facilitating early detection and intervention.http://dx.doi.org/10.1155/2024/9935805
spellingShingle Yi-Jing Zhao
Yong Li
Feng-Xiang Wang
Hao Lv
Yaoyao Qu
Lian-Wen Qi
Pingxi Xiao
Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
Cardiovascular Therapeutics
title Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
title_full Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
title_fullStr Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
title_full_unstemmed Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
title_short Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model
title_sort improved risk prediction of acute myocardial infarction in patients with stable coronary artery disease using an amino acid assisted model
url http://dx.doi.org/10.1155/2024/9935805
work_keys_str_mv AT yijingzhao improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT yongli improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT fengxiangwang improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT haolv improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT yaoyaoqu improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT lianwenqi improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel
AT pingxixiao improvedriskpredictionofacutemyocardialinfarctioninpatientswithstablecoronaryarterydiseaseusinganaminoacidassistedmodel